Atlas Trials

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Clinical trial NCT01062503 · COMPLETED

Trial details

NCT number
NCT01062503
Sponsor
University Health Network, Toronto
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Prostate CancerBone Metastasis
Start date
2010-01-01
Primary completion
2014-06-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.